Patients needing intensive care admission have associated acute and sometimes previous chronic illness. They are staged within the first 24 h based on scoring systems according to their mortality risk. For several years, these scoring systems have demonstrated its utility as prognostic tools. We use different versions of acute physiology and chronic health evaluation (APACHE) or simplified acute physiology score (SAPS). When a patient is affected by an in ICU event such as ventilator-associated pneumonia his or her predicted mortality risk might be affected. It is lacked a scoring system for stratify patients at the time of VAP diagnosis. Taking the scoring system for oncology, a group of intensive care experts designed a scoring system for patients with infection, the PIRO system. PIRO has four components: predisposition (P), infection insult (I), host response (R) and organ dysfunction (O). Mixing the idea and the necessity VAP PIRO score try to take place as prognostic tool to be applied at the time of VAP diagnosis.
Keywords
- Chronic Obstructive Pulmonary Disease
- Chronic Obstructive Pulmonary Disease Patient
- Intensive Care Unit Admission
- Respir Crit
- Sequential Organ Failure Assessment Score
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Rello J, Diaz E (2003) Pneumonia in the intensive care unit. Crit Care Med 31:2544–2551
Chastre J, Fagon JY (2002) Ventilator-associated pneumonia. Am J Respir Crit Care Med 165:867–903
Fine MJ, Auble TE, Yealy DM, et al. (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243–250
Lim WS, van del Eerden MM, Laing R, et al. (2003) Defi ning community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377–388
American Thoracic Society (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated and healthcare-associated Pneumonia. Am J Respir Crit Care Med 171:388–416
Rello J, Sole-Violan J, Sa-Borges M, et al. (2005) Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides. Crit Care Med 33:1983–1987
Rello J, Rue M, Jubert P, et al. (1997) Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. Crit Care Med 25:1862–1867
Bone RC, Balk RA, Cerra FB, et al. (1992) Defi nitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655
Levy MM, Fink MP, Marshall JC, et al. (2003) International Sepsis Defi nitions Conference 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Defi nitions Conference. Intensive Care Med 29:530–538
Moreno RP, Metnitz B, Adler L, et al. (2008) Sepsis mortality prediction based on predisposition, infection and response. Intensive Care Med 34:496–504
Shorr AF, Cook D, Jiang X, et al. (2008) Correlates of clinical failure in ventilator-associated pneumonia: insights from a large, randomized trial. J Crit Care 23:64–73
Hedrick TL, Smith RL, McElearney ST, et al. (2008) Differences in early- and late-onset ventilator-associated pneumonia between surgical and trauma patients in a combined surgical or trauma intensive care unit. J Trauma 64:714–720
Myny D, Depuydt P, Colardyn F, Blot S (2005) Ventilator-associated pneumonia in a tertiary care ICU: analysis of risk factors for acquisition and mortality. Acta Clin Belg 60:114–121
National Heart, Lung, and Blood Institute. Morbidity & mortality: chartbook on cardiovascular, lung, and blood diseases. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health; 1998. Available from: URL: http://www.nhlbi.nih.gov/nhlbi/seiin//other/cht-book/htm
Rabe K, Hurd S, Anzueto A, et al. (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (GOLD). Am J Respir Crit Care Med 176:532–555
Nseir S, Di Pompeo C, Soubrier S, et al. (2005) Impact of ventilator-associated pneumonia on outcome in patients with COPD. Chest 128:1650–1656
Ibrahim EH, Tracy L, Hill C, et al. (2001) The occurrence of ventilator-associated pneumonia in a community hospital. Risk factors and clinical outcomes. Chest 120:555–561
Mistiaen W, Visseres D (2008) The risk of postoperative pulmonary or pleural complications after aortic valve replacement is low in elderly patients: an observational study. Aust J Physiother 54:119–124
Cook DJ, Walter SD, Cook RJ, et al. (1998) Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Int Med 129:433–440
Osmon S, Warren D, Seiler SM, et al. (2003) The infl uence of infection on hospital mortality for patients requiring >48 h of intensive care. Chest 124:1021–1029
Liebler JM, Benner K, Putnam T, Vollmer WM (1991) Respiratory complications in critically ill medical patients with acute upper gastrointestinal bleeding. Crit Care Med 19:1152–1157
Tran DD, Groeneveld AB, van der Meulen J, et al. (1990) Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med 18:474–479
Ely EW, Laterre PF, Angus DC, et al. (2003) Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med 31:12–19
Vallés J, Pobo A, García-Esquirol O, et al. (2007) Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early vs late onset. Intensive Care Med 33:1363–1368
Diaz E, Muñoz E, Agbaht, K, Rello J (2007) Management of ventilator-associated pneumonia caused by multiresistant bactéria. Curr Opin Crit Care 13:45–50
Rello J, Jubert P, Vallés J, et al. (1996) Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 23:973–978
Rello J, Sole-Violan J, Sa-Borges M, et al. (2005) Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides. Crit Care Med 33:1983–1987
Garnacho J, Sole-Violan J, Sa-Borges M, et al. (2003) Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study. Crit Care Med 31:2478–2482
Schulert GS, Feltman H, Rabin SD, et al. (2003) Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia. J Infect Dis 188:1695–706
Garcia-Vidal C, Fernández-Sabé N, Carratalà J, et al. (2008) Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J 32:733–739
Agbath K, Diaz E, Muñoz E, et al. (2007) Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbac-teremic ventilator-associated pneumonia. Crit Care Med 35:2215–2226
Vidaur L, Gualis B, Rodriguez A, et al. (2005) Clinical resolution in patients with suspicion of ventilator-associated pneumonia: A cohort study comparing patients with and without acute respiratory distress syndrome. Crit Care Med 33:1248–1253
Vidaur L, Planas K, Sierra R, et al. (2008) Ventilator-associated pneumonia: impacto f organisms on clinical resolution and medical resources utilization. Chest 133:625–632
Tejerina E, Frutos-Vivar F, Restrepo MI, et al. (2006) Incidence, risk factors, and outcome of ventilator-associated pneumonia. J Crit Care 21:56–65
Seligman R, Meisner M, Lisboa TC, et al. (2006) Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 10:R125
Vincent JL, de Mendonça A, Cantraine F, et al. (1998) Use of the SOFA score to assess the incidence of organ dysfunction failure in intensive care units: Results of a multicentric prospective study. Crit Care Med 26:1793–180
Lopes Ferreira F, Peres Bota D, Bross A, et al. (2001) Serial evaluation of the SOFA score to predict outcome JAMA 286:1754–1758
Steinvall I, Bak Z, Sjoberg F (2008) Acute kidney inury is common, parallels organ dysfunction or failure, and carries appreciable mortality in patients with major burns: a prospective exploratory cohort study. Crit Care 12(5):R124
Rodriguez A, Lisboa T, Blot S, et al. (2009) Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough. Intensive Care Med 35:430–438
Bernard GR, Artigas A, Brigham KL et al. (1994) The American—European Consensus Conference on ARDS. Defi nitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818–824
Phua J, Badia JR, Adhikari NK, et al. (2009) Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med 179(3): 220–227
Markowicz P, Wolff M, Djedaïni K, et al. (2000) Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. ARDS Study Group. Am J Respir Crit Care Med 161:1942–1948
Wunderink RG, Waterer GW (2002) Pneumonia complicating the acute respiratory distress syndrome. Sem Respir Crit Care Med 23:443–448
Lisboa T, Diaz E, Sa-Borges M, et al. (2008) The ventilator-associated pneumonia PIRO score: a tool for predicting ICU mortality and helath-care resources use in ventilator-associated pneumonia. Chest 134:1208–1216
Baker AM, Meredith JW, Haponik EF (1996) Pneumonia in intubated trauma patients. Microbiology and outcomes. Am J Respir Crit Care Med 153:343–349
Hedrick T, Smith R, McElearney S, et al. (2008) Difference in early- and late-onset ventilator-associated pneumonia between surgical and trauma patients in a combined surgical or trauma intensive care unit. J Trauma 64:714–720
Koulenti D, Lisboa T, Brun-Buisson C, et al. (2009) The Spectrum of Practice in the Diagnosis of Nosocomial Pneumonia in Patients Requiring Mechanical Ventilation in European ICUs. Crit Care Med (in press)
Rello J, Gallego M, Mariscal D, et al. (1997) The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 156:196–200
Teixeira PJ, Seligman R, Hertz FT, et al. (2007) Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes. J Hosp Infect 65:361–367
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Díaz, E., Lisboa, T. (2009). Ventilator-Associated Pneumonia PIRO Score. In: Rello, J., Díaz, E., Rodríguez, A. (eds) Management of Sepsis: The PIRO Approach. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-00479-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-00479-7_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-00478-0
Online ISBN: 978-3-642-00479-7
eBook Packages: MedicineMedicine (R0)